GPT and metabolic dysfunction-associated steatotic liver disease: There was no significant difference in sex, age, WC, BMI, SBP, DBP, FPG, TG, TC, HDL-C, LDL-C, ALT, AST, GGT, SUA, WBC, NLR, MTTP, MTTP mutations, and the incidence of NAFLD between the training set and the verification set (P > 0.05).